NFKB1 and stroke disorder: Consistent with immunostaining, Western blot assay show that D-4F treatment of T1DM stroke rats decreases TLR4, and nuclear NFκB expression in the ischemic brain (Figure 4a) compared to PBS treated T1DM stroke control rats.